Ono and Galapagos subsidiary BioFocus sign an additional target discovery agreement in the field of

Vor 6 Stunden  Wallstreet Online

Mechelen, Belgium; 30 May 2012 - Galapagos NV (Euronext: GLPG) and Ono Pharmaceutical Co., Ltd. (TSE: 4528) announced today that they have signed an additional collaboration agreement focused on discovering novel targets in the ... mehr

Diskutieren Sie mit zu diesem Thema:
Kommentar schreiben

Sie können noch 400 Zeichen eingeben